Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
February 28, 1997
Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors
T Kolasa, C D Brooks, K E Rodriques, et al.
Journal of Medicinal Chemistry
|
September 1, 1988
3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation
F Haviv, J D Ratajczyk, R W DeNet, et al.
Journal of Medicinal Chemistry
|
November 1, 1987
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase
J B Summers, B P Gunn, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist
D H Albert, T J Magoc, S D Menacherry, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1995
Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors
R L Bell, J B Bouska, P E Malo, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1997
Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis
R L Bell, R R Harris, J B Bouska, et al.
Journal of Medicinal Chemistry
|
December 23, 1994
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist
S K Davidsen, J B Summers, D H Albert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1996
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist
D H Albert, R G Conway, T J Magoc, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones
P A Bhatia, C D Brooks, A Basha, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1995
ABT-299, a potent antagonist of platelet activating factor
J B Summers, D H Albert, S K Davidsen, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
February 28, 1997
Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors
T Kolasa, C D Brooks, K E Rodriques, et al.
Journal of Medicinal Chemistry
|
September 1, 1988
3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation
F Haviv, J D Ratajczyk, R W DeNet, et al.
Journal of Medicinal Chemistry
|
November 1, 1987
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase
J B Summers, B P Gunn, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist
D H Albert, T J Magoc, S D Menacherry, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1995
Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors
R L Bell, J B Bouska, P E Malo, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1997
Characterization of A-93178, an iminoxy-quinoline inhibitor of leukotriene biosynthesis
R L Bell, R R Harris, J B Bouska, et al.
Journal of Medicinal Chemistry
|
December 23, 1994
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist
S K Davidsen, J B Summers, D H Albert, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1996
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist
D H Albert, R G Conway, T J Magoc, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones
P A Bhatia, C D Brooks, A Basha, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|
January 1, 1995
ABT-299, a potent antagonist of platelet activating factor
J B Summers, D H Albert, S K Davidsen, et al.
Page
of 8